Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-003738
Filing Date
2019-03-07
Accepted
2019-03-07 16:15:17
Documents
1
Period of Report
2019-03-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3096
  Complete submission text file 0001213900-19-003738.txt   4520
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 140 RIVERSIDE DRIVE APT. 9K NEW YORK NY 10024
Business Address
Berger Mark Stanley (Reporting) CIK: 0001700283 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 19666022